uating the extension of lesions (11) . Therefore, a modality that precisely evaluates the nature of AD is critical and needed.
Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) has proven to be the most sensitive method for detecting breast cancer (12, 13) ; however, controversy remains regarding the specificity of this modality, given that previous publications reported a wide range of specificities from 21% to 100% (14) (15) (16) . One possible solution to improve this is to apply apparent diffusion coefficient (ADC) values derived from diffusion-weighted image (DWI) to characterize breast tumors, and promising results have been reported by studies that combined ADC values and DCE-MRI in data analysis (17) (18) (19) (20) (21) (22) . Nevertheless, few investigations have specifically evaluated MRI findings of AD detected by mammography, and moreover, the standard MRI scanning techniques have evolved since publication of these studies (23, 24) . Therefore, we aimed to evaluate the diagnostic accuracy of the current standard MRI combined with DWI in the characterization of lesions that manifest with AD on mammography.
Methods

Subjects
A retrospective review of records in the medical database was performed for 396 consecutive women who underwent fullfield digital mammography (FFDM) and subsequent breast MRI examinations for various indications, including preoperative staging, equivocal mammographic findings, palpable breast mass but equivocal mammography and sonography, and nipple discharge, at our hospital between August 2010 and January 2013. After investigating all FFDM and MRI data, 57 lesions showing AD in 56 patients with complete pathologic results or two-year follow-up data were included in this analysis. The institutional ethics review committee approved this study, and written informed consent from enrolled patients was waived due to the retrospective nature of this study.
MRI was always carried out before obtaining histopathologic results. All patients underwent MRI and FFDM within 14 days. None of the observed breast tissue was surgically altered before MRI examination.
Malignant lesions were confirmed by histo pathology results from biopsies or surgical excisions, and benign lesions were confirmed by pathology results or two-year follow-up observation. BI-RADS categories 1-3 were considered negative, and BI-RADS categories 4-5 were considered positive for the analysis.
FFDM examination
Standard craniocaudal (CC) and mediolateral oblique (MLO) viewing of the breast with full-field digital mammography (FFDM, Senographe DS GE Healthcare) is routinely performed at our institution.
MRI technique
MRI was performed using a 3.0 Tesla scanner (TimTrio, Siemens) with a four-channel bilateral breast surface coil. Patients were imaged in prone position. The MRI protocol is shown in Table 1 according to the acquisition order. ADC maps were created automatically by the MRI system software from the DWI images. During the DCE-MRI image acquisition, 0.1 mmol/kg bodyweight of gadopentetate dimeglumine (Gd-DTPA, Magnevist, Bayer Healthcare) was injected intravenously as a bolus of 3 mL/s by an automatic injector, followed immediately by a 20 mL saline solution flush.
Image interpretation
All FFDM and MRI data were reviewed by the same two blinded radiologists who have six and 12 years experience in breast imaging. The readers first evaluated FFDM images without patient identification and corresponding MRI scans, and then assessed MRI scans without referencing FFDM images. After the evaluation was done, both radiologists had access to all imaging data, and controversial findings were discussed by the two radiologists until consensus was reached. BI-RADS was used as the reference standard for AD (1) .
The AD lesions detected by FFDM were classified as lesions with or without calcification(s). Readers described the breast tissue density, lesion location, shape of calcifications, and other associated findings (skin
Main points
• Architectural distortion (AD) is the third most common mammographic manifestation of nonpalpable breast cancer. Primary AD, including all causes without a known history of breast intervention, trauma, or infection, has been found to be associated with breast malignancy in one-half to two-thirds of the cases in which it was observed.
• Primary AD is subtle and particularly difficult to detect by mammography. Furthermore, AD does not always exhibit ultrasound features, which increases the difficulty of subsequent biopsy verification.
• We found that normalized ADC (nADC) (AUC=0.819) is more accurate than absolute ADC (AUC=0.749) for revealing malignancy, based on the higher AUC value of the former.
• DCE-MRI combined with nADC values was more reliable than mammography and DCE-MRI in evaluating the nature of disease manifesting as primary AD in mammography. The MRI findings were reviewed in three steps. In the first step, readers had access only to the DCE-MRI data. They were blinded to the current clinical evaluation and FFDM findings, whereas the data for patients' personal history of breast cancer and prior MRI were available. If an enhanced lesion was discovered, the location, lesion type, shape, border, distribution, kinetics, and internal architecture were carefully recorded according to the BI-RADS lexicon. Based on the above findings, the final MRI assessment was performed according to BI-RADS for MRI. The classification scheme is summarized in Table 2. The second step included analysis of FFDM images, and this information was subsequently correlated with DCE-MRI results to obtain a new general BI-RADS classification (BI-RADS DCE-MRI+FFDM) using a five-point scale (1, negative; 2, benign finding; 3, probable benign finding; 4, suspicious abnormality; 5, highly suggestive of malignancy) according to the following principle: if FFDM revealed fine pleomorphic or fine linear calcification, the case was classified as BI-RADS 5, regardless of the manifestation on DCE-MRI; the other AD lesions were classified into different BI-RADS categories based on DCE-MRI manifestation. Finally, DWI findings and ADC maps were obtained. The mean absolute ADC for the suspicious lesion of interest (ADC int ) and the glandular tissue (ADC ref ) were calculated. The normalized ADC (nADC) was then calculated using the following formula: nADC=ADC int /ADC ref . DCE-MRI combined with nADC values was also used to obtain a new BI-RADS classification (BI-RADS DCE-MRI+ADC) using the same five-point scale indicated for the second step.
For each lesion detected on DCE-MRI, a region of interest (ROI) was defined at the corresponding location on the ADC images. The ROI was drawn freehand to include the area of hypointensity to encompass as much of the abnormality as possible. ROIs for evaluation of normal fibroglandular tissue were placed on the contralateral breast at areas where no suspicious lesions were reported. Care was taken to avoid regions with high T2 signal within a lesion, such as a cyst, hematoma, or necrosis, by verifying the ROI against the T2-weighted image. In case a lesion was not hyperintense on DWI, the ROI was drawn at the corresponding location on a DCE-MRI image presenting a suspicious lesion. BI-RADS, breast imaging reporting and data system; nADC, normalized apparent diffusion coefficient; NME, non-mass enhancement.
Differential diagnosis of primary architectural distortion in the breast
Statistical analysis
Receiver operating characteristic (ROC) curve analysis was carried out to determine the threshold ADC value to differentiate malignant from benign breast lesions. We determined the best cutoff value using Youden statistics, Y=sensitivity-(1-specificity), which allows a balance between high sensitivity and specificity. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of FFDM, DCE-MRI, FFDM+DCE-MRI, and DCE-MRI+ADC were calculated based on a gold standard of pathologic or follow-up results. We calculated 95% confidence intervals (CIs) from the normally approximated binomial distribution. We compared the ADC values and nADC values of two groups using the Mann-Whitney U test and analyzed categorical data using Fisher exact test and Fisher-Freeman-Halton test. P < 0.05 was considered statistically significant. All statistical analyses were performed using SPSS 17.0 (SPSS Inc.) and MedCalc 10.5.4 (MedCalc Software).
We analyzed false-positive and false-negative cases to clarify the limitations of using MRI for differential diagnosis.
Results
A total of 57 lesions from 56 patients (age range, 27-78 years; median age, 48 years) were analyzed. Forty-five lesions were verified by surgical pathology findings and/or percutaneous biopsy, and the remaining 12 benign lesions were verified by follow-up for ≥2 years, during which no malignancy was observed at the location of primary suspicion.
Histologic diagnoses included 28 malignanct (17 invasive ductal carcinomas, seven ductal carcinoma in situ, one invasive lobular carcinoma, two mucinous carcinoma, one apocrine carcinoma) and 17 benign lesions (one plasma cell mastitis, three fibrocystic diseases, one fibroadenomas, four intraductual papillomas, three atypical ductal epithelial hyperplasia, and five sclerosing adenosis).
The ADC int values of malignant and benign lesions were 1. Table 3 . The ADC int values and nADC values of malignant lesions were lower than those of the benign lesions, and the differences were statistically significant independent of the presence of calcification (P = 0.011 and P = 0.002 with calcification, respectively, and P = 0.026 and P = 0.002 without calcification, respectively).
The ROC curves are shown in Fig. 1 . When the threshold of ADC int was set at 1.19×10 -3 mm 2 /s, the sensitivity and specificity were 72.4% and 85.7%, respectively. For a nADC value threshold of 0.61, the sensitivity and specificity were 93.1% and 75.0%, respectively. The area under the curve (AUC) for nADC was higher than that for ADC int (0.819 vs. 0.749, respectively, P = 0.011).
An example of the typical presentation of AD on mammography and DCE-MRI and the corresponding pathologic findings are shown in Fig. 2 . Table 4 reveals the association between the individual modalities and their histopathology/follow-up results, and shows the corresponding sensitivity, specificity, PPV, and NPV values of each modality. The sensitivity of DCE-MRI was higher than that of FFDM (89.3% vs. 78.6%), but this difference was not significant (P = 0.510). The specificity of DCE-MRI alone was significantly higher than that of FFDM (P = 0.039). DCE-MRI+ADC provided even higher specificity compared with DCE-MRI (79.3% vs. 41.4%, respectively; P = 0.010), without a significant decrease in the sensitivity. The sensitivity of FFDM+DCE-MRI was higher than that of DCE-MRI, but the difference was not significant (92.9% vs. 89.3%, P = 1.000). The specificities of the two methods were equal (41.4%). No statistically significant difference was observed between the performances of DCE-MRI and FFDM+DCE-MRI. Table 3 shows the diagnostic sensitivities and specificities for AD with and without calcification. There was a statistically significant difference between the specificity of FFDM and that of DCE-MRI+ADC (P = 0.003) in detecting underlying disease showing AD without calcification, and the same difference was revealed between DCE-MRI and DCE-MRI+ADC (P = 0.023). Similarly, a significant difference was observed between the specificity of FFDM and that of DCE-MRI+ADC in identifying lesions showing AD with calcification (P = 0.008). The diagnostic sensitivity of FFDM did not differ significantly for AD with and without calcification (P = 0.354). The six false-negative cases included eight lesions without calcification and one lesion with calcification.
Among 11 benign AD lesions with calcification, there were two coarse heterogeneous, two amorphous, one fine pleomorphic, and six punctate calcifications; in 22 malignant AD lesions with calcification, three coarse heterogeneous, two amorphous, nine fine pleomorphic, seven fine linear, and one punctate calcification were observed. Punctate calcification was more commonly seen in benign lesions (P = 0.003). As shown in Table 5 , AD mainly man- ifests as mass (22/57, 38.6%) and non-mass enhancement (NME, 26/57, 45.6%), which contributes to the majority of lesion types on MRI (P = 0.01). However, no difference was found in the proportion of malignancy between mass-like and NME lesions (P = 0.600). In 22 mass lesions, malignancy was more likely to present an irregular shape (P = 0.030) and uncircumscribed margin (P = 0.010). Of 26 NME lesions, 13 showed segmental distribution and five presented clustered ring internal enhancement; however, no statistical difference was observed between benign and malignant lesions (P = 0.120 and P = 0.190, respectively). There were no statistical differences when considering MRI background parenchymal enhancement, mass and NME internal enhancement, and NME distribution in verifying malignancy. A significantly higher percentage of malignant lesions was detected in cases showing high T2 signal intensity (P = 0.024) and kinetic curves classified as "washout" (P = 0.001).
The six false-positive cases identified upon applying the DCE-MRI+ADC value consisted of one case of plasma cell mastitis (showing NME with regional distribution, clustered ring internal enhancement, washout kinetic curve, ADC int <1. 
Discussion
In this study, the specificity of DCE-MRI for revealing malignancy related to AD was significantly higher than that of FFDM. In addition, the combination of ADC values improved the specificity of DCE-MRI, independent of the presence of calcification in the lesion.
We found the specificity of FFDM for AD lesions as 10.3%, which is lower than the specificity of 39.7% for breast cancer reported by a previous study (25) . Lesions showing AD are challenging to diagnose and remain a common cause of false-negative mammography, because of subtlety and variability in presentation. The six false-negative cases included eight lesions without calcification and one lesion with calcification. The specificity of DCE-MRI for detecting breast cancer is controversial, ranging from 21% to 100%. A previous study by Cilotti et al. (26) showed no statistically significant difference between the specificities of mammography and MRI for the diagnosis of calcified lesions. In our study, the specificity of DCE-MRI alone was higher than that of FFDM alone. Current research evaluating the potential of DWI for improving breast imaging is promising. Recent single-center studies have shown that ADC measures are complementary to DCE-MRI parameters for differentiation of benign and malignant breast lesions and may increase the accuracy of conventional breast MRI assessment (17, 19) . Ei Khouli et al. (17) showed that ADC values significantly improved the ability of DCE-MRI to discriminate between benign and malignant lesions. Yabuuchi et al. (21, 22) concluded that the application of DWI together with DCE-MRI contributes to an improved diagnostic accuracy of breast MRI. We found that DCE-MRI combined with ADC values provides a higher specificity than DCE-MRI in AD lesions detected by FFDM, independent of whether calcification is present in the lesion. Thus, with the combination of DCE-MRI and ADC, it might be possible to avoid both unnecessary surgical procedures for benign lesions and inadequate observation for potential malignancies presenting AD. Nevertheless, these possible advantages should be further investigated in a future study with a larger population and longer follow-up. FFDM, full-field digital mammography; DCE-MRI, dynamic contrast-enhanced magnetic resonance imaging; AD, architectural distortion; MRI, magnetic resonance imaging; NME, non-mass enhancement.
Our results also showed the preferable sensitivity of DCE-MRI (89.3%) and DCE-MRI combined with ADC (92.9%) compared with that of FFDM (78.6%). However, no statistically significant differences were observed among the sensitivities of the three modalities. The diagnostic sensitivity of FFDM for AD with calcification appeared to be higher than that for AD without calcification, but the difference was not statistically significant. This could be due to the relatively small sample size. In addition, FFDM is more sensitive for lesions with calcification. In our study, more than 50% of the cases presented with calcification(s) (33/57), and this may also explain our results. Another interesting finding in this study was that the calcification shape showed no difference between benign and malignant lesions except for punctuate calcification, which is not consistent with the findings of a previous study by Uematsu et al. (27) . The latter one showed that 25% of amorphous morphology microcalcifications, 64% of pleomorphic morphology microcalcifications, and 92% of linear morphology microcalcifications were malignant. However, it only evaluated screening mammography in detecting pure microcalcification lesions.
Differential diagnosis of primary architectural distortion in the breast We found that nADC (AUC=0.819) is more accurate than ADC int (AUC=0.749) for revealing malignancy, based on the higher AUC value of the former. This result is also consistent with those of previous studies. EI Khouli et al. (17) [28] [29] [30] [31] [32] . Our study revealed an absolute ADC threshold value within this range. However, some overlap remained in the ADC between benign and malignant lesions, and the degree of overlap was substantially reduced by normalizing the ADC values to those of remote glandular tissue. We observed improvement in the diagnostic model when normalized ADCs were added to conventional MRI data. These results suggest a potential role for nADC values in improving the diagnostic performance of breast MRI for AD lesions detected by FFDM.
In our study, AD detected by FFDM mainly manifested as mass (22/57, 38.6%) and NME (26/57, 45.6%) in DCE-MRI, and no significant differences were observed between benign and malignant lesions. The proportion of malignancy was noticeably higher within masses with an irregular shape and those without a circumscribed margin. The irregular shape and uncircumscribed margins of mass lesions on MRI could be missed in FFDM due to tissue overlap and the simple appearance of AD showing spiculations radiating from a point or focal retraction. However, with the help of MRI, the risk of missed diagnosis can be lowered.
Although DCE-MRI+ADC presented remarkably high sensitivity, there were still false-positive cases in this study. However, all of these cases manifested with NME and an ADC int less than the threshold value. Typical causes of NME include mastopathic changes, fibrocystic changes due to hormonal stimulation, inflammatory changes in benign lesions or ductal carcinoma in situ (DCIS), invasive lobular carcinoma, and some cases of estrogen receptor-negative invasive ductal carcinoma. A previous study reported that NME was the major cause of false-positive breast findings (33) . A previous study by Partridge et al. (32) reported that for the same b value, the diagnostic performance of ADC was lower in NME lesions compared with masses larger than 1 cm (34) . Another study carried out by the same researchers also suggested that ADC measurements may be more valuable for distinction of masses than for differentiating lesions with NME (35) . We also found that there was no statistical difference when considering NME internal enhancement and NME distribution in verifying malignancy. This finding is not consistent with that of a previous study by Tozaki et al. (36) who found that segmental distribution, heterogeneous internal enhancement, and clustered ring enhancement were the most frequent findings in malignant NME. Some specific tumor subtypes, such as papillary carcinoma, are associated with the lowest ADC values among malignant breast tumors (37) . On the other hand, their ADC values are very similar to those observed for benign papillomas (38) , indicating the histologic similarity between benign and malignant papillary lesions. A diagnostic challenge is also encountered with percutaneous core biopsy and dynamic breast MRI. In addition, sclerosing adenosis can be difficult to distinguish from infiltrating carcinoma. No specific MRI findings have been described for this diagnosis. Usually, ultrasonography does not reveal a focal abnormality, although in minority of cases, a circumscribed mass may be seen with the nodular variant of this condition.
The false-negative cases included one case of DCIS and one case of mucinous carcinoma. In our work, the DCIS case showed focal enhancement and DWI was negative. It is difficult to apply morphologic descriptors in small focal enhancement, and some tiny foci in DCE-MRI could be artifacts. Accordingly, BI-RADS descriptors are currently not applied to assess morphologic and dynamic profiles of foci (39) . In addition, previous studies reported that the ability of DWI to detect lesions smaller than 1 cm is limited due the limited ability of ADC maps to depict smaller lesions (27, 38) . A later study was able to evaluate all lesions detected with contrast-enhanced MRI, including lesions with a diameter less than 1 cm, which accounted for less than 50% of lesions studied by Partridge et al. (32) . In clinical practice, AD in the setting of DCIS is thought to be attributable to a mixture of sclerosing adenosis, sclerosis in the interstitium around the DCIS, and DCIS involving Cooper's ligaments. Prior publications have shown that DCIS with an area of AD occurs in about 7%-13% of the cases (40, 41) . In our study, the case of DCIS showed focal enhancement and DWI was negative, although focal enhancement is the least common finding, being seen in only 1%-12% of cases (42, 43) . The reported sensitivity of MRI for the detection of DCIS is lower than that for the detection of invasive breast cancers. The case of mucinous carcinoma displayed the highest ADC values, a high signal in T2-weighted imaging, a circumscribed margin, and a persistent enhanced pattern on the kinetic curve in this study. Also, the size of the tumor was small (<1 cm). All the above characteristics led to a misdiagnosis of fibroadenoma.
Some other limitations in our study still require further investigation. First, this was a retrospective study including only a small number of patients. Second, we did not compare the diagnostic performance of ultrasonography, given that more than one-third of the patients' ultrasonography results were performed at an outside hospital and could not be obtained. In addition, we have no pathologic confirmation in 12 of 29 benign cases. Nonetheless, these cases showed no evidence of malignancy in physical examination, mammography, MRI, or sonography and were followed for two years, which suggests the benign nature of the lesions. Finally, this work presents potential selection bias, given that we included more cases with calcification than ones without calcification. A prospective study enrolling a larger cohort should be conducted to verify the results presented in this work.
In conclusion, the combination of DCE-MRI and ADC values is valuable for improving the specificity for disease manifesting as primary AD detected by mammography. Breast MRI can be a useful tool when an equivocal finding of AD is presented on conventional mammography.
